Simplifying Track & Trace in Uzbekistan & Kazakhstan with Yudge

As pharmaceutical companies expand into Central Asia, markets like Uzbekistan and Kazakhstan are becoming increasingly attractive, but also significantly more complex.
Their advanced Track & Trace systems introduce requirements that go beyond standard EU serialization, creating a gap between existing infrastructures and local compliance.

The real challenge is not just meeting regulations: it’s adapting quickly without disrupting established operations.

Rather than redesigning their systems from scratch, companies are turning to automated connections and smart Track & Trace connectors to bridge this gap, enabling seamless integration between global platforms and local authorities.

A new layer of complexity in Central Asia

Both Uzbekistan and Kazakhstan have implemented robust Track & Trace systems to strengthen drug safety and combat counterfeiting. However, unlike many European frameworks, these systems introduce additional technical layers that significantly impact serialization processes.

The most critical difference is the introduction of government-issued cryptocodes, which must be combined with standard serial numbers. In other words, serialization is no longer just about generating unique IDs: it becomes a synchronized process between company systems and national authorities.

At the same time, both countries require continuous reporting of product lifecycle events, ensuring full traceability from production to distribution.

The integration challenge for European Pharma Companies

For European manufacturers, the issue is immediate: their existing Level 4 systems are designed for EU or global standards, but not for these specific local requirements.

This creates several challenges:

• managing additional data elements like cryptocodes;
• handling new event types and reporting logic;
• connecting to multiple national platforms with different protocols;
• preserving validated production processes.

Many companies initially address this with manual processes or custom integrations. But these approaches quickly become inefficient, costly and difficult to scale.

Automated connections: the missing link

The real enabler for these markets is not a new system, but a smarter way to connect existing ones. This is where Track & Trace connectors come into play.

Rather than rebuilding their infrastructure, pharmaceutical companies can leverage dedicated connectors that bridge their existing Level 4 systems with local regulatory platforms.

These connectors allow companies to adapt their current serialization lines to Uzbekistan and Kazakhstan requirements, without redesigning their global architecture.

The results:

• seamless data exchange;
• automated handling of country-specific logic;
• faster and more efficient market entry.

Yudge: turning complexity into connectivity

This is exactly where Yudge makes the difference.

As a Level 4 solution, Yudge goes beyond orchestration, since it provides the integration layer that connects global systems to local realities.
Through its modular architecture, Yudge includes dedicated connectors designed for specific markets, enabling pharmaceutical companies to extend their existing serialization setup instead of reworking it entirely.

These connectors handle the most critical operations automatically:

• combining company-generated serial numbers with government-issued cryptocodes, managing orders for production;
• distributing enriched data to Level 3 systems;
• collecting and validating production events;
• communicating with national platforms (ASL Belgisi, OMS, CEDM).

In a nutshell, Yudge acts as a translator between global standards and local regulatory logic, ensuring that every data exchange is compliant, complete, and correctly structured. Instead of forcing companies to adapt their infrastructure, Yudge allows them to adapt their connectivity.

How it works: from Provisioning to Posting

1. Provisioning: serial numbers meet cryptocodes

In Uzbekistan and Kazakhstan, serialization starts with a coordinated process:

• Level 5 provides cryptocodes (identified by GS1 Application Identifiers 91 and 92);
• Level 4 generates serial numbers;
• Yudge combines them into an order.

This merged dataset is then sent to Level 3 and applied during production.

2. Production and event generation

At Level 3:

• products are serialized;
• aggregation is performed;
• events are generated.

These events are automatically sent back to Level 4.

3. Posting: full visibility for authorities

Once production is complete, Level 4 reports back to the national systems, providing full visibility on how serial numbers and cryptocodes have been used.

Uzbekistan

In Uzbekistan, the Level 5 system requires detailed traceability of all assigned codes.
At this stage, Level 4 sends event data to the national platform (ASL Belgisi), including:

• product status utilization, confirming whether a product can be released to the market;
• tracking of all crypto-enabled serials throughout their lifecycle;
• event aggregation management.

Additionally, in case of de-aggregation, Level 4 must notify Level 5 through a specific rework aggregation event, ensuring that any change in packaging hierarchy is properly recorded.

Kazakhstan

In Kazakhstan, the posting logic is similar but requires more granular and structured reporting.
Level 4 must submit different types of events, including:

• utilization → confirmation that serial numbers have been used;
• aggregation → definition of packaging hierarchy (e.g., case, pallet);
• dropout → decommissioning of invalid or discarded serial numbers.
  

The complexity increases further due to the presence of multiple systems:

• OMS platform, which manages orders and serial lifecycle events;
• CEDM system, which handles aggregation and logistics-related operations.

4. Beyond standard flows: foreign shipment

Advanced operations such as foreign shipment must also be managed.

This includes:

• scanning pallets;
• confirming transfers;
• specifying destination companies;
• notifying national systems.

Another example of how local requirements extend beyond standard serialization logic.

From complexity to scalability

The real challenge in these markets is not serialization itself, but the synchronization between serial numbers and cryptocodes, combined with country-specific reporting logic.
Without the right approach, this becomes overwhelming. With the right connectors, it becomes scalable.
By leveraging automated connections and dedicated Track & Trace connectors, pharmaceutical companies can:

• extend existing systems instead of replacing them;
• manage complex local requirements seamlessly;
• accelerate time-to-market;
• maintain a consistent global architecture.

Ultimately, success in these markets depends on one key capability: the ability to bridge global systems and local rules quickly, efficiently and without disruption. And that bridge is built through smart connectivity.

Request information